Results 161 to 170 of about 1,969,671 (301)

Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives

Preventive cancer vaccines are highly effective in preventing viral infection-induced cancer, but advances in therapeutic cancer vaccines with a focus on eliminating cancer cells through immunotherapy are limited.
Lixing Weng, Yujie Ren, Jiaming Jin, Tingming Liang, Dekang Ren, Shizheng Xiong, Li Guo, Xinmiao Zhao, Xueni Yang, Miaomiao Xu   +9 more
core   +1 more source

Detaching Photosensitive Nanoparticles from Cells Prevents Them from Remaining in Cells after Photoporation

Advanced Science, EarlyView.
Phenylboronic acid‐functionalized gold nanoparticles reversibly attach to cell‐surface glycans, enhancing photoporation‐mediated intracellular delivery. After irradiation, ATP competitively disrupts the boronic ester interactions and removes cell‐associated nanoparticles, markedly reducing residual gold.
Tao Lu, Mina Nikolić, Baihao Huang, Deep Punj, Herlinde De Keersmaecker, Thibaut Van Acker, Wenjia Xie, Florian Vanlauwe, Phillip Blondeel, Liesl De Graeve, Félix Sauvage, Ranhua Xiong, Chaobo Huang, Frank Vanhaecke, Kevin Braeckmans, Stefaan C. De Smedt   +15 more
wiley   +1 more source

Head and neck cancer therapeutic vaccines: a review. [PDF]

Front Oncol
Huetteman A, Rabinowits G.
europepmc   +1 more source

Multimodal Imaging of Hypoxia, Metabolism and pH in Feline Sarcoma Using Hyperpolarized 13C MRI and PET

Advanced Science, EarlyView.
This work presents a clinically deployable simultaneous PET/MRI workflow which integrates hyperpolarized 13C imaging of metabolism and extracellular pH with [18F]FMISO PET to characterize hypoxia, acidosis, and metabolic reprogramming in feline sarcoma.
Martin Grashei, Tanja Groll, Stephanie Kahl, Silke Baer, Elisabeth Bliemsrieder, Frits H. A. van Heijster, Andre Wendlinger, Pascal Wodtke, Jorge Cabello, Susan Notohamiprodjo, Christian Lohrmann, Markus Schwaiger, Wolfgang A. Weber, Katja Steiger, Andrea Meyer‐Lindenberg, Johannes Hirschberger, Christine Baumgartner, Franz Schilling   +17 more
wiley   +1 more source

Clinical landscape of therapeutic vaccines for ovarian cancer: current status, challenges, and future directions. [PDF]

J Ovarian Res
Shan Y, Wang Q, Wan W, Zhang Y, Chu Y.
europepmc   +1 more source

Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer. [PDF]

Pharmaceutics, 2023
Firdaus FZ, Bartlett S, Hussein WM, Lu L, Wright Q, Huang W, Nahar UJ, Yang J, Khongkow M, Veitch M, Koirala P, Ruktanonchai UR, Monteiro MJ, Gonzalez Cruz JL, Stephenson RJ, Wells JW, Toth I, Skwarczynski M.   +17 more
europepmc   +1 more source

Therapeutic recreation in mental health, from an Australian perspective : it's not just campfires and kangaroos

, 2017
Therapeutic recreation in Australia is a developing profession; therapeutic approaches of recreation to healthcare in particular mental health are still developing in a risk aware, medicalised model of care (Pegg & Lord, 2008).
Alford, Stewart (R19505)
core  

NS1‐Induced PARP1 Phase Transitions Prolongs Host Transcriptional Pausing to Promote Influenza A Virus Replication

Advanced Science, EarlyView.
After IAV infection, NS1 induces PARP1 phase transition, reducing molecular mobility in condensates, prolonging host transcriptional pause, aiding RdRp cap snatching, and promoting viral transcription. ABSTRACT Influenza A virus (IAV) commandeers host transcriptional machinery to replicate, but mechanisms remain elusive.
Shufeng Ma, Changyuan Kang, Xixian Liu, Lichao Yang, Mengyi Li, Yuting Ye, Jianfang Zhang, Yingjun Li, Guanghui Jin, Yang Liu, Xiaohong Chen, Kexin Wang, Zifeng Yang   +12 more
wiley   +1 more source

Therapeutic Vaccines for Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma. [PDF]

Vaccines (Basel)
Baliton M, Alfatlawi D, Attarian S, Nabar R, Villaflor V.   +4 more
europepmc   +1 more source

Recent Progress on Therapeutic Vaccines for Breast Cancer. [PDF]

Front Oncol, 2022
Zhang L, Zhou X, Sha H, Xie L, Liu B.
europepmc   +1 more source